Business
Press Release Sep 13 2023
Bajaj Healthcare Limited has informed the Exchange regarding a press release dated September 13, 2023, titled "Receipt of the Establishment Inspection Report (EIR) from the United State Food and Drug Administration (USFDA), for the Pre-approval inspection that was carried out by the USFDA in November, 2022".
About this update from Bajaj Healthcare Ltd
[{"type":"text","content":" Bajaj Healthcare Limited has informed the Exchange regarding a press release dated September 13, 2023, titled \"Receipt of the Establishment Inspection Report (EIR) from the United State Food and Drug Administration (USFDA), for the Pre-approval inspection that was carried out by the USFDA in November, 2022\". View Attachment","length":515,"tagName":"div"}]